Study on influence of extended care on living quality of patients after allogeneic hematopoietic ste

来源 :第十五届全国实验血液学学术会议 | 被引量 : 0次 | 上传用户:i369731392
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Aim To evaluate the influence of extended care on living quality of patients after allogeneic hematopoietic stem transplantation.Methods A total of 80 patients after allogeneic hematopoietic stem transplantation were enrolled in this study.They were randomly divided into intervention group and control group according to hospital number ending(odd and even numbers).The intervention group cases were given the extended care after discharging from hospital, but no intervention for the control group,and the quality of life was evaluated by using cancer patients quality of life measure scale developed by European Organization for research and treatment of cancer(EORTC) in the two groups at 1 month and 3 months after discharged.Results At 1 month after discharge,the cognitive function score and emotion function score in intervention group were better than that of control group;at 3 months after discharge,the scores of physical function,role function,cognitive function,social function,general health status and fatigued,insomnia symptoms in intervention group were better than that of control group.Conclusion: Extended care for patients after allogeneic hematopoietic stem transplantation can effectively improve the quality of life of them.
其他文献
Background Peripheral-blood (PB) and bone marrow (BM) are both widely used in hematopoietic stem cell transplantation (HSCT).However, it has been controversial whether the use of PB or BM leads to a m
Background Dysfunction of gap junctional intercellular communication (GJIC) is a common characteristic of tumorigenesis.Each connexin presents tissue or cell-specific expression, and gap junction gene
目的 总结阵发性睡眠性血红蛋白尿症(paroxysmal nocturnal hemoglobinuria,PNH)患者的临床特点,提高对PNH的认识.方法 (1)收集2013年12月至2015年05月于我院就诊的46例PNH患者,予外周血FLAER技术检测PNH克隆,统计其临床表现、实验室检查结果、并发症并进行随访.(2)将46例患者按照PNH国际工作组(I-PIG)标准,根据患者的临床特征、骨
目的 探讨非清髓性异基因造血干细胞移植(NST)治疗T细胞淋巴瘤的安全性和疗效。方法 采用NST治疗T细胞淋巴瘤3例,均接受人类白细胞抗原全相合的同胞供给的异基因造血干细胞移植。预处理方案:马利兰+氟达拉滨+环磷酰胺,移植物抗宿主病(GVHD)预防:环孢素联合短疗程甲氨喋呤。
目的 观察异基因造血干细胞移植(allo-SCT)治疗恶性淋巴肿瘤的疗效.方法 回顾性分析自2007年9月至2015年2月于我院进行allo-SCT治疗的23例复发难治及具高危因素的恶性淋巴肿瘤患者,其中男性13例、女性10例,中位年龄48岁(14~61岁).B细胞淋巴瘤16例,其中弥漫大B细胞淋巴瘤(DLBCL)6例、套细胞淋巴瘤(MCL)2例、慢性淋巴细胞白血病(CLL)4例、B淋巴母细胞淋巴
Autoimmune diseases (ADs) have close relationship with the onset of malignant lymphoma.The recent research focuses on ADs such as sjogrens syndrome (SS), rheumatoid arthritis (RA), systemic lupus eryt
目的 探讨血管免疫母T细胞淋巴瘤(AITL)患者的初诊外周血单核细胞绝对计数(AMC)的临床意义及对预后的影响.方法 收集我院2008年3月至2014年4月经病理确诊的47例初治AITL患者的临床资料.47例患者均接受了CHOP或CHOP-like方案化疗.回顾性分析患者初诊时AMC与临床特征之间的关系,包括国际预后指数(IPI)、外周T细胞淋巴瘤预后指数(PIT)、血管免疫母T细胞淋巴瘤预后指数
Background Almost all patients can achieve complete remission (CR) since the introduction of tyrosine kinase inhibitors(TKI) in the combination chemotherapy regimens for newly diagnosedPhiladelphia ch
Aims The detection of fetal liver tyrosine kinase 3 (FLT3) internal tandem duplications (ITDs) has been used as a powerful adverse prognostic indicator for acute myeloid leukemia (AML) in any age grou
目的 探讨骨髓的PET参数在淋巴瘤合并噬血细胞综合征(LA-HLH)患者中的价值。方法 回顾性分析我院2009年8月至2014年3月住院的34例初治LA-HLH患者临床资料。所有患者在初始治疗前均接受PET-CT以及骨髓穿刺和活检检查。我们对所有患者PET-CT上11处骨骼(T10-T12、L2-L4、肱骨、股骨、髂前上棘、髂后上棘、胸骨)最大标准摄取值(SUVmax)进行了测定。